Abstract
The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 marked the second introduction of a highly pathogenic coronavirus into the human population in the twenty-first century. The continuing introductions of MERS-CoV from dromedary camels, the subsequent travel-related viral spread, the unprecedented nosocomial outbreaks and the high case-fatality rates highlight the need for prophylactic and therapeutic measures. Scientific advancements since the 2002-2003 severe acute respiratory syndrome coronavirus (SARS-CoV) pandemic allowed for rapid progress in our understanding of the epidemiology and pathogenesis of MERS-CoV and the development of therapeutics. In this Review, we detail our present understanding of the transmission and pathogenesis of SARS-CoV and MERS-CoV, and discuss the current state of development of measures to combat emerging coronaviruses.
MeSH terms
-
Animals
-
Camelus / virology
-
Communicable Diseases, Emerging / prevention & control
-
Communicable Diseases, Emerging / virology*
-
Coronavirus Infections / immunology
-
Coronavirus Infections / therapy
-
Coronavirus Infections / transmission
-
Coronavirus Infections / virology*
-
Cross Infection
-
Disease Outbreaks / prevention & control
-
Humans
-
Immune Evasion
-
Middle East Respiratory Syndrome Coronavirus / pathogenicity*
-
Middle East Respiratory Syndrome Coronavirus / physiology
-
Middle East Respiratory Syndrome Coronavirus / ultrastructure
-
Pandemics / prevention & control
-
Severe Acute Respiratory Syndrome / immunology
-
Severe Acute Respiratory Syndrome / transmission
-
Severe Acute Respiratory Syndrome / virology*
-
Severe acute respiratory syndrome-related coronavirus / pathogenicity*
-
Severe acute respiratory syndrome-related coronavirus / physiology
-
Severe acute respiratory syndrome-related coronavirus / ultrastructure
-
Travel
-
Virus Replication